Diabetes News: Diabetes News

Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743

May-Yun Wang, Hai Yan, Zhiqing Shi, Matthew R. Evans, Xinxin Yu, Young Lee, Shiuhwei Chen, Annie Williams, Jacques Philippe, Michael G. Roth, Roger H. Unger, Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 2503- 2508 ,(2015) , 10.1073/PNAS.1424934112

Lenore J Launer, Michael E Miller, Jeff D Williamson, Ron M Lazar, Hertzel C Gerstein, Anne M Murray, Mark Sullivan, Karen R Horowitz, Jingzhong Ding, Santica Marcovina, Laura C Lovato, James Lovato, Karen L Margolis, Patrick O'Connor, Edward W Lipkin, Joy Hirsch, Laura Coker, Joseph Maldjian, Jeffrey L Sunshine, Charles Truwit, Christos Davatzikos, R Nick Bryan, Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy Lancet Neurology. ,vol. 10, pp. 969- 977 ,(2011) , 10.1016/S1474-4422(11)70188-0

Komelia Kotseva, David Wood, Guy De Backer, Dirk De Bacquer, Kalevi Pyörälä, Željko Reiner, Ulrich Keil, , EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries European Journal of Preventive Cardiology. ,vol. 17, pp. 530- 540 ,(2010) , 10.1097/HJR.0B013E3283383F30

Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman, Matthew A Cavender, Jacob A Udell, Nihar R Desai, Ofri Mosenzon, Darren K McGuire, Kausik K Ray, Lawrence A Leiter, Itamar Raz, Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus The New England Journal of Medicine. ,vol. 369, pp. 1317- 1326 ,(2013) , 10.1056/NEJMOA1307684

G Pacini, A Mari, P Fouqueray, S Bolze, M Roden, None, Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes Diabetes, Obesity and Metabolism. ,vol. 17, pp. 541- 545 ,(2015) , 10.1111/DOM.12452

William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer, Craig Wilson, William C Cushman, Faiez Zannad, None, Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes The New England Journal of Medicine. ,vol. 369, pp. 1327- 1335 ,(2013) , 10.1056/NEJMOA1305889

Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn, John M Lachin, Darren K McGuire, Michael J Pencina, Eberhard Standl, Peter P Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D Peterson, Rury R Holman, None, Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes The New England Journal of Medicine. ,vol. 373, pp. 232- 242 ,(2015) , 10.1056/NEJMOA1501352

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi, None, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. The New England Journal of Medicine. ,vol. 373, pp. 2117- 2128 ,(2015) , 10.1056/NEJMOA1504720

Andy Menke, Sarah Casagrande, Linda Geiss, Catherine C. Cowie, Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012 JAMA. ,vol. 314, pp. 1021- 1029 ,(2015) , 10.1001/JAMA.2015.10029